These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1717595)

  • 21. [Study of the antigenic structure of human immunodeficiency virus using synthetic peptides].
    Ivanov VS; Chikin LD; Suvorova ZK; Kozhich AT; Ivanov VT
    Bioorg Khim; 1992 Jun; 18(6):784-93. PubMed ID: 1384509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals.
    Burton DR; Barbas CF; Persson MA; Koenig S; Chanock RM; Lerner RA
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10134-7. PubMed ID: 1719545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyclonal antiidiotypic antibodies mimicking gp120 of HIV-1.
    Sperlagh M; Hoxie J; Maruyama H; Stefano K; Gonzales-Scarano F; Prewett M; Liang S; Matsushita S; Herlyn D
    Viral Immunol; 1994; 7(2):61-9. PubMed ID: 7531443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discrimination between HIV-1 and HIV-2-seropositive individuals using mouse monoclonal antibodies directed to HIV transmembrane proteins.
    Hunt JC; Johnson-Paepke J; Boardway K; Gutierrez R; Hampl H; Allen R; Heynen C; Desai S; Casey J; Tribby I
    AIDS Res Hum Retroviruses; 1990 Jul; 6(7):883-98. PubMed ID: 2202352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How an improved immunoassay sensitivity can be achieved by gamma irradiation: modification, application and characterization of polystyrene surface for anti HIV-1 ELISA.
    Feng B; Dai Y; Zhang H; Wang L; Ding Y; Zeng H
    J Immunoassay Immunochem; 2009; 30(4):457-66. PubMed ID: 19739018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1-specific polyclonal and monoclonal antibodies raised with synthetic peptides: characterization and applications.
    Laman JD; Schellekens MM; Paddenburg D; Tersmette M; Langedijk JP; Boersma WJ; Claassen E
    Year Immunol; 1993; 7():63-8. PubMed ID: 7690509
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-human immunodeficiency virus type 1 human monoclonal antibodies that bind discontinuous epitopes in the viral glycoproteins can identify mimotopes from recombinant phage peptide display libraries.
    Boots LJ; McKenna PM; Arnold BA; Keller PM; Gorny MK; Zolla-Pazner S; Robinson JE; Conley AJ
    AIDS Res Hum Retroviruses; 1997 Dec; 13(18):1549-59. PubMed ID: 9430247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of monoclonal antibodies against the p17 core protein of the human immunodeficiency virus 1.
    Cogniaux J; De Schepper N; Blondiau ML; Cornet B; Horal P; Vahlne A
    J Immunol Methods; 1990 Apr; 128(2):165-75. PubMed ID: 1691236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-reactive potential of rabbit antibodies raised against a cyclic peptide representing a chimeric V3 loop of HIV-1 gp120 studied by biosensor technique and ELISA.
    Richalet-Sécordel PM; Deslandres A; Plaué S; You B; Barré-Sinoussi F; Van Regenmortel MH
    FEMS Immunol Med Microbiol; 1994 Jun; 9(1):77-87. PubMed ID: 7920467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allergenic and antigenic determinants of latex allergen Hev b 1: peptide mapping of epitopes recognized by human, murine and rabbit antibodies.
    Chen Z; Van Kampen V; Raulf-Heimsoth M; Baur X
    Clin Exp Allergy; 1996 Apr; 26(4):406-15. PubMed ID: 8732237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Peptides from the principal neutralizing and CD4-binding domain: similar immunoreactive properties and structure pattern].
    Meshcheriakova DV; Andreev SM; Sidorova MV; Vafina MG; Az'muko AA; Petrukhina AO; Khaitov RM
    Vestn Ross Akad Med Nauk; 1992; (9-10):47-52. PubMed ID: 1283721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides.
    Neurath AR; Strick N; Lee ES
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():85-95. PubMed ID: 1689372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-idiotypic antibodies to the third variable domain of gp120 induce an anti-HIV-1 antibody response in mice.
    Boudet F; Theze J; Zouali M
    Virology; 1994 Apr; 200(1):176-88. PubMed ID: 7510435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
    Filice G; Soldini L; Orsolini P; Razzini E; Gulminetti R; Campisi D; Chiapparoli L; Cattaneo E; Achilli G
    Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of antibodies to the envelope protein of the human immunodeficiency virus by immunization with monoclonal anti-idiotypes.
    Zaghouani H; Goldstein D; Shah H; Anderson S; Lacroix M; Dionne G; Kennedy R; Bona C
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5645-9. PubMed ID: 2062842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a synthetic peptide that mimics an HIV glycoprotein 120 envelope conformational determinant exposed following ligation of glycoprotein 120 by CD4.
    Weinberg J; Liao HX; Torres JV; Matthews TJ; Robinson J; Haynes BF
    AIDS Res Hum Retroviruses; 1997 May; 13(8):657-64. PubMed ID: 9168234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human antibodies to immunodominant C5 region of HIV-1 gp120 cross-react with HLA class I on activated cells.
    de Santis C; Lopalco L; Robbioni P; Longhi R; Rappocciolo G; Siccardi AG; Beretta A
    AIDS Res Hum Retroviruses; 1994 Feb; 10(2):157-62. PubMed ID: 7515259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [An enzyme-linked immunosorbent assay determining anti-principal neutralizing determinant antibodies using synthetic peptides deduced from cDNA sequences of HIV-1 V3 loop domain].
    Ishimoto S; Fujimura Y; Yamanaka T; Shimoyama T; Nishida S; Matsuoka H; Nishikawa K; Yoshioka A; Narita N; Honda M
    Rinsho Ketsueki; 1995 Mar; 36(3):193-9. PubMed ID: 7540222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A potent, neutralizing human monoclonal antibody against a unique epitope overlapping the CD4-binding site of HIV-1 gp120 that is broadly conserved across North American and African virus isolates.
    Pinter A; Honnen WJ; Racho ME; Tilley SA
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):985-96. PubMed ID: 7506556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A versatile synthetic peptide-based ELISA for identifying antibody epitopes.
    Ball JM; Henry NL; Montelaro RC; Newman MJ
    J Immunol Methods; 1994 May; 171(1):37-44. PubMed ID: 7513733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.